H2020-SC1-PHE-CORONAVIRUS-2020
H2020-SC1-PHE-CORONAVIRUS-2020
- Programme
- H2020
- Funded projects (dataset)
- 18
- EU contribution (sum)
- €67,755,562
- Portal deadline
- —
Leading topic in historical projects: SC1-PHE-CORONAVIRUS-2020
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- KI3 coordinated
- Leiden University Medical Center1 coordinated
- TECHNICAL UNIVERSITY OF DENMARK DTU1 coordinated
- DOMPE FARMACEUTICI SPA1 coordinated
- EPICONCEPT1 coordinated
- ERASMUS MC1 coordinated
- ICN2-CERCA1 coordinated
- HMGU1 coordinated
- HZI1 coordinated
- Hibergene Diagnostics Ltd1 coordinated
- UCPH1 coordinated
- RTDS Association (RTDS)1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- INSERM3 topic projects
- RIVM3 topic projects
- ADLEGO BIOMEDICAL AB2 topic projects
- CSIC2 topic projects
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2 topic projects
- FOHM2 topic projects
- IP2 topic projects
- INMI2 topic projects
- KU Leuven2 topic projects
- SSI2 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- 2 shared
- 2 shared
- 2 shared
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS · IP2 shared
FR ↔ FR
- 2 shared
- 2 shared
- 1 shared
- 1 shared
- 1 shared
- Fraunhofer · BSC CNS1 shared
DE ↔ ES
- Fraunhofer · ELETTRA1 shared
DE ↔ IT
- Fraunhofer · UNINA1 shared
DE ↔ IT
- Fraunhofer · DOMPE FARMACEUTICI SPA1 shared
DE ↔ IT
- Fraunhofer · UMIL1 shared
DE ↔ IT
- Fraunhofer · INMI1 shared
DE ↔ IT
- 1 shared
- Fraunhofer · INFN1 shared
DE ↔ IT
- Fraunhofer · POLIMI1 shared
DE ↔ IT
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 9.33
- Median orgs / project
- 7
- Min / max orgs
- 3 – 33
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- France22
- Netherlands21
- Italy20
- Germany18
- Spain13
- Sweden13
- United Kingdom12
- Belgium10
- Denmark7
- Switzerland7
- China5
- Poland4
- Austria3
- Portugal2
- Finland2
- Ireland2
- Nepal1
- United States1
Organization types
- research_institute52 orgs · 62 rows
- university50 orgs · 60 rows
- sme15 orgs · 16 rows
- public_body11 orgs · 11 rows
- other9 orgs · 10 rows
- company9 orgs · 9 rows
Topics in funded projects
- SC1-PHE-CORONAVIRUS-2020SC1-PHE-CORONAVIRUS-2020· 18 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| RECoVER Rapid European SARS-CoV-2 Emergency research Response | H2020 | €19,995,195 |
| ATAC Antibody therapy against coronavirus (COVID-19) | H2020 | €5,595,040 |
| EpiPose Epidemic intelligence to minimize 2019-nCoV’s public health, economic and social impact in Europe | H2020 | €4,548,391 |
| MANCO Monoclonal Antibodies against 2019-New Coronavirus | H2020 | €3,034,581 |
| OPENCORONA Rapid therapy development through Open nCoronavirus Vaccine Platform | H2020 | €3,000,000 |
| EXSCALATE4CoV EXaSCale smArt pLatform Against paThogEns for Corona Virus | H2020 | €2,970,875 |
| CORONADX Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 CoronaThree Rapid Diagnostic tests (Point-of-Care) for Coronavirus, improving epidemic preparedness, public health and socio-economic benefits | H2020 | €2,970,209 |
| HERoS Health Emergency Response in Interconnected Systems | H2020 | €2,855,410 |
| I-MOVE-COVID-19 Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic | H2020 | €2,808,163 |
| Fight-nCoV FIGHTING-OFF CORONAVIRUS (SARS-CoV-2) WITH BROAD-SPECTRUM ANTIVIRALS: ESTABLISHING ANIMAL VIRAL CHALLENGE MODEL | H2020 | €2,807,026 |
| CoroNAb Nanobodies and antibodies against 2019-nCoV | H2020 | €2,771,658 |
| CORESMA COVID-19-Outbreak Response combining E-health, Serolomics, Modelling, Artificial Intelligence and Implementation Research | H2020 | €2,759,195 |
| Prevent-nCoV Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine | H2020 | €2,728,340 |
| SCORE Swift COronavirus therapeutics REsponse | H2020 | €2,576,063 |
| CoNVat Combating 2019-nCoV: Advanced Nanobiosensing platforms for POC global diagnostics and surveillance | H2020 | €2,547,152 |